00:01
So first of all, the double blind, if this is double blind, that means that both the volunteers and the, i'll call them the treaters, the people that are giving the treatments, don't know whether they're receiving the ginkgo or the placebo.
00:35
They don't know.
00:36
And that's important because if the volunteers knew what they were getting, then they could end up wanting to prove it one way or the other.
00:44
And same thing with the treaters.
00:46
If they knew that somebody was getting a placebo, it could be that they would maybe treat the people differently and kind of think that they're not going to respond.
00:54
Can we generalize this to a larger population? no, we can't.
00:59
These were given to people who were over 60 and years old.
01:03
And so we can't generalize this to a larger group or say to everybody that the effects are the same.
01:11
And cause and effect, well, you are doing an experiment where you're having this done.
01:18
So if you're controlling everything else, then there's possibility.
01:24
On part c, on part c, the 350 volunteers is much better than having 30 volunteers because we want as much repetition as we can...